2019-2020 Session
Change SessionH.626
An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration
- Sponsor(s)
- Location
- House Committee on Health Care
- Last Recorded Action
- House 1/10/2020 - Read First Time and Referred to the Committee on Health Care
Bill/Resolution Text
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration
Detailed Status
Regular Session 2019-2020
Body | Date | Journal | Calendar | Location | Full Status |
---|
An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration
Roll Call History
Regular Session 2019-2020
Body | Date | Journal | Location | Full Status |
---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration
Committee Meetings
Regular Session 2019-2020
Meeting Date | Committee |
---|
An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration
Meeting Full List
Regular Session 2019-2020
Friday, January 17, 2020
- Committee(s):
- House Committee on Health Care
- -
-
H.626 - An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration
Rep. George W. Till, Sponsor
Thursday, January 30, 2020
- Committee(s):
- House Committee on Health Care
- 10:05 AM
-
H.626 - An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration
Rep. George W. Till, Sponsor
Jessica Chung, Resident from UVMMC
Committee Documents
An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration
Witnesses Who Testified
Regular Session 2019-2020
House Committee on Health Care
- Jessica Chung, Resident from UVMMC
- Rep. George W. Till, Sponsor
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
No fiscal documents found for H.626 in the Regular Session 2019-2020.
No committee of conference members found for H.626 in the Regular Session 2019-2020.
An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration
Committee of Conference Meetings
Regular Session 2019-2020
Meeting Date | Committee |
---|